Cancer Institute (WIA)
Dr. Shirley Sunder Singh

Dr. Shirley Sunder Singh

Professor, Department of Cancer Biology & Molecular Diagnostics

Breast CancerHead & Neck Cancer
miRNA ProfilingMolecular DiagnosticsHead & Neck Cancer

Lab News & Discoveries

Indigenous CAR-T Therapy Achieves 90% Remission in Relapsed Leukaemia Trial

8 March 2026

Indigenous CAR-T Therapy Achieves 90% Remission in Relapsed Leukaemia Trial

Locally manufactured CAR-T cells show remarkable efficacy at a fraction of international costs, bringing hope to patients with relapsed blood cancers.

Novel PARP Inhibitor Combination Shows Promise in Platinum-Resistant Ovarian Cancer

20 December 2025

Novel PARP Inhibitor Combination Shows Promise in Platinum-Resistant Ovarian Cancer

A first-in-India trial combining a PARP inhibitor with an ATR inhibitor demonstrates activity in heavily pre-treated ovarian cancer patients.

Institute Launches Comprehensive Childhood Cancer Survivorship Program

18 November 2025

Institute Launches Comprehensive Childhood Cancer Survivorship Program

A new multidisciplinary program will track long-term health outcomes in childhood cancer survivors and develop interventions to reduce late treatment effects.

View all news →

Research

miRNA profiling in triple-negative breast cancer, molecular diagnostics for head and neck cancers

Research Interests

miRNA ProfilingMolecular DiagnosticsHead & Neck Cancer

Contact

Department of Cancer Biology & Molecular Diagnostics

Cancer Institute (WIA), Adyar, Chennai — 600 036

shirley.singh@cancerinstitutewia.org